Shanghai Argo Biopharmaceutical Co., Ltd.
Clinical trials sponsored by Shanghai Argo Biopharmaceutical Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug BW-50218 put to first safety test in healthy chinese volunteers Results expected Jun 2027 (estimated)
- New drug BW-50218 begins first human safety tests Results expected Jun 2027 (estimated)